Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab

J Med Virol. 2020 Oct;92(10):1791-1792. doi: 10.1002/jmv.25907. Epub 2020 Jun 3.

Authors

Austin R Morrison¹, Joseph M Johnson¹, Mayur Ramesh², Patrick Bradley³, Jeffery Jennings³, Zachary R Smith¹

Affiliations

¹ Department of Pharmacy, Henry Ford Hospital, Detroit, Michigan.
² Department of Infectious Diseases, Henry Ford Hospital, Detroit, Michigan.
³ Pulmonary and Critical Care Medicine Division, Henry Ford Hospital, Detroit, Michigan.

No abstract available

Keywords: coronavirus; disease control; immune responses; immunodulators; interleukin; virus classification.

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
COVID-19*
Humans
Hypertriglyceridemia* / chemically induced
Pandemics
Pneumonia, Viral* / epidemiology
SARS-CoV-2

Substances

Antibodies, Monoclonal, Humanized
tocilizumab